Other atai Life Sciences Announces First Subject Dosed in Phase 1 Trial of Buccal and IV VLS-01, a Synthetic Form of DMT October 5, 2022
Other atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day October 5, 2022
Other MindMed Collaborators Initiate Phase 1 Comparative PK/PD Trial of R-, S- and Racemic MDMA October 5, 2022
Other atai Life Sciences Announces Initiation of Phase 1 Trial for its MDMA Derivative, EMP-01 September 27, 2022
Other MindMed Collaborators Dose First Patient in Phase 1 Investigator-Initiated Trial of MDMA-Like Substances September 20, 2022
Other Healthy Extracts Launches Whitney Johns Citrus Bergamot for Women’s Heart Health and Overall Health Exclusively on Amazon September 20, 2022
Other Seelos Therapeutics Announces the Participation of Acadia Healthcare in the Registration Directed Study of SLS-002 (Intranasal Racemic Ketamine) for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder September 13, 2022